HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effects of aprepitant in daily administrations of low-dose cisplatin].

AbstractOBJECTIVE:
While aprepitant is actually recommended for the prevention of nausea and vomiting induced by a single cisplatin administration, it is still unclear whether it has a clinical benefit when administered along with daily administrations of low- dose cisplatin(20mg/m2 days 1-5). This study was conducted to evaluate the efficacy of aprepitant in patients receiving daily administration of low-dose cisplatin.
METHODS:
Our study focused on 25 patients who received cancer therapy including cisplatin, with or without aprepitant (days 1-5). We performed a retrospective study to identify any significant positive effect of aprepitant in the prevention of nausea and vomiting for 10 days(days 1-10). Because cisplatin has a long half-life, we assessed the delayed phase nausea and vomiting(days 6-10).
RESULTS AND CONCLUSION:
Multiple-day dosing of aprepitant was effective for prevention of nausea(Odds ratio: 0. 30, p= 0. 0012)and vomiting(Odds ratio: 0. 04, p=0. 0001)throughout the observation. Furthermore, we observed a significant positive effect of aprepitant in the prevention of delayed nausea(Odds ratio: 0. 19, p=0. 0083)and vomiting(Odds ratio: 0. 07, p=0. 0040). These findings suggest that multiple-day dosing of aprepitant is useful for the inhibition of acute delayed nausea and vomiting caused by chemotherapy including daily administration of low-dose cisplatin.
AuthorsMisato Kariya, Kenta Tanaka, Kumiko Matsumoto, Manabu Kume, Hiroo Makimoto, Takeshi Hirano, Hideaki Miyake, Masato Fujisawa, Midori Hirai
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 39 Issue 2 Pg. 245-50 (Feb 2012) ISSN: 0385-0684 [Print] Japan
PMID22333636 (Publication Type: Journal Article)
Chemical References
  • Morpholines
  • Aprepitant
  • Cisplatin
Topics
  • Adult
  • Aprepitant
  • Cisplatin (administration & dosage, adverse effects)
  • Female
  • Humans
  • Male
  • Morpholines (administration & dosage, therapeutic use)
  • Nausea (chemically induced, prevention & control)
  • Retrospective Studies
  • Vomiting (chemically induced, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: